unknown
Stage
2
Investors
About
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing aqueous outflow in glaucoma treatment through bio-interventional and micro-interventional devices.
Explore Iantrek's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.